Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Bon Health vs Breeze Meds

Bon Health
Graded #93

Lower grade

vs+1
Breeze Meds
Graded #56

Higher grade

The verdict

Breeze Meds takes it — 72.4/100 to 71.4/100, but only just.

Breeze Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Charges nothing until a provider approves you — but keeps its pricing inside the intake. Bon Health is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBreeze Meds +14
58
72
Dose & formulationBon Health +11
77
66
Clinical oversightBon Health +9
85
76
Labs & monitoringBon Health +5
65
60
FulfillmentBon Health +4
88
84
Contract termsBreeze Meds +33
53
86
Bon Health · left barBreeze Meds · right bar

The numbers

MetricBon HealthBreeze Meds
WeighScore71.4/10072.4/100
GradeCC
Scorecard rank#93#56
Semaglutide$170/mo (annual plan, compounded)From $199/mo
Tirzepatide$170/mo (annual plan, compounded)From $299/mo first month, $399/mo thereafter
CoverageAll 50 statesAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Bon Health

Graded #93 · C

Strengths

  • Transparent commitment-tier pricing from $170/mo (annual) for compounded semaglutide and tirzepatide; $0 membership fee, cancel anytime
  • Physician-led: comprehensive medical review and physician-titrated dosing, not a 2-minute quiz
  • 24/7 physician support included free with your order; 1-3 day rapid dispatch
  • Licensed in all 50 states; uses 503A & 503B compounding pharmacies; brand-name Wegovy/Ozempic/Zepbound/Mounjaro also offered

Where it loses points

  • Best rates require a 6- or 12-month commitment ($170-195/mo); month-to-month is $330/mo
  • Doesn't name its specific compounding pharmacy
  • No legal entity name or LegitScript certification shown on the site
  • Compounded GLP-1s are not FDA-approved (the site discloses this)
Breeze Meds

Graded #56 · C

Strengths

  • Nothing charged until a provider approves you, and the consult is free if you go ahead
  • One inclusive price covering consult, medication, supplies, shipping and support
  • LegitScript certified, all 50 states, cancel or change plan at any time
  • NAD+ injections offered alongside the GLP-1 line

Where it loses points

  • The public site names no molecule behind its "from $199" — tirzepatide pricing appears only inside the intake
  • Every quoted figure is for the LOWEST dose; the funnel says higher doses may cost more
  • An $80 consultation fee applies if you are approved and then decline
  • Injection only, compounded only, with no published lab programme

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard